Product
Deuremidevir Hydrobromide
Aliases
VV116
3 clinical trials
4 indications
Indication
Liver Function InjuryIndication
Normal Liver FunctionIndication
Healthy SubjectsIndication
Respiratory Syncytial Virus InfectionsClinical trial
An Open-label, Single-dose, Phase I Study to Assess the Pharmacokinetics and Safety of JT001 in Subjects With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionStatus: Completed, Estimated PCD: 2023-08-18
Clinical trial
A Phase I Clinical Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetic Characteristics of Oral Deuremidevir Hydrobromide for Suspension in Chinese Healthy VolunteersStatus: Completed, Estimated PCD: 2023-09-04
Clinical trial
A Multiple-dose, Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension in Chinese Healthy VolunteersStatus: Completed, Estimated PCD: 2024-05-06